Question 1

Am I eligible for this trial based on my current treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors clinical trial (NCT05983133). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of PF-08046052/SGN-EGFRd2?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors clinical trial (NCT05983133). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors clinical trial (NCT05983133). Contact the study team or your healthcare provider for specific answers.

Question 4

What will my participation involve in terms of visits and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors clinical trial (NCT05983133). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors clinical trial (NCT05983133). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors clinical trial (NCT05983133). Contact the study team or your healthcare provider for specific answers.

What this study is about